Linker for activation of T cells (LAT) is a transmembrane adaptor protein playing a key role in the development, activation and maintenance of peripheral homeostasis of T cells. In this study we identified a functional isoform of LAT. It originates from an intron 6 retention event generating an in-frame splice variant of LAT mRNA denoted as LAT i6 . Comparison of LAT i6 expression in peripheral blood leukocytes of human and several other mammalian species revealed that it varied from being virtually absent in the mouse to being predominant in the cow. Analysis of LAT isoform frequency expressed from minigene splicing reporters carrying loss-or gain-of-function point mutations within intronic polyguanine sequences showed that these elements are critical for controlling the intron 6 removal. The protein product of LAT i6 isoform (LAT i6 ) ectopically expressed in LAT-deficient JCam 2.5 cell line localized correctly to subcellular compartments and supported T-cell receptor signaling but differed from the canonical LAT protein by displaying a shorter half-life and mediating an increased interleukin-2 secretion upon prolonged CD3/CD28 crosslinking. Altogether, our data suggest that the appearance of LAT i6 isoform is an evolutionary innovation that may contribute to a more efficient proofreading control of effector T-cell response.
INTRODUCTION
Intron retention (IR) is a relatively uncommon form of alternative splicing among vertebrates, accounting for B5-15% of all alternative splicing events. 1, 2 Apart from hippocampal dendrites and platelets in which activation-induced extranuclear splicing was shown to promote translation of cytoplasmic intron-retaining RNA transcripts, 3 it is generally believed that IR may primarily be involved in post-transcriptional reduction of gene expression, often associated with normal cellular differentiation. 4, 5 Two major mechanisms accounting for this reduction are a nonsensemediated decay and an increase of microRNA targets within retained, 3 0 -untranslated regions. 6, 7 Other documented functions of intron-retaining transcripts involve generation of distinct, often truncated proteins endowed with modified biological activity, [8] [9] [10] altered subcellular localization [11] [12] [13] or turnover. 14 Despite intense research, the exact mechanism of IR remains unclear. It usually concerns small introns (100-200 nt), flanked by suboptimal splice signals and polypyrimidine tract sequences. 2 It is postulated that mutations among conserved cis-regulatory elements are sufficient to direct the majority of species-specific alternative splicing patterns including IR. 15 For example, an inverse correlation of IR with the density of intronic polyguanosine splicing enhancers (ISE GGG) has been reported for a number of intron-retaining transcripts. [16] [17] [18] The activity of these cis-acting elements, especially arranged in tandem guanosine quadruplet (G 4 NG 4 ) upstream of branch point (BP) sites, was shown to be enhanced for exons containing weak or intermediate-strength 5 0 splicing sites (5 0 ss). 13, 19 Linker for activation of T cells (LAT) is an adaptor molecule nucleating juxtamembrane signaling complexes involved in signal transduction through the immune receptors of T cells, natural killer (NK) cells, mast cells, megakaryocytes and numerous T/NK neoplasms. [20] [21] [22] [23] Targeted mutations of the LAT gene in the mouse revealed its critical role in the development, activation and maintenance of peripheral homeostasis of T cells. [24] [25] [26] The activity of LAT undergoes post-translational modulation, mainly by phosphorylation of tyrosine and serine residues 27, 28 and by palmitoylation of cysteine residues. 29 In addition, ubiquitylation 30 and partial proteolytic degradation 31, 32 of LAT have been recognized as strategies for attenuation of T-cell signaling. In this report we identified a signaling-competent short-lived isoform of LAT that mediated increased long-term interleukin-2 (IL-2) secretion upon CD3/CD28 crosslinking. This isoform originates from an intron 6 retention event within LAT mRNA. We detected the expression of LAT i6 transcripts in lymphoid tissues of five mammals. Moreover, we have shown that the abundance of LAT i6 transcripts inversely correlates with the density of ISE GGG elements present in the LAT intron 6.
RESULTS

Detection of LAT i6 transcripts
The mRNA sequences of human LAT (RefSeq accession: NM_001014987.1, NM_014387.3, NM_001014989.1 and NM_001014988.1) available in CDS Database (CCDS Release 15; 29 November 2013) confirm the existence of a transcript (NM_014387.3) that retains intron 6. In one published report, this splice variant was also detected in human fetal brain complementary DNA (cDNA). 33 The orthologous intron 6-retaining transcripts of LAT are in silico predicted by the Ensembl gene build engine 34 for six eutherian mammals including the pig (ENSSSCT_8559), the cow (ENSBTAT_28315), the cat (ENSFCAT_18321), the dog (ENSCAFT_44423), the ferret (ENSMPUT_12997) and the panda (ENSAMET_17299). However, to our knowledge, the physiological expression of the human LAT i6 or its orthologous transcripts in lymphoid cells has not been reported so far. Moreover, given that intron-retaining splice variants are often associated with neoplasms, 14, 35 we wished to find out whether the LAT i6 expression varied between normal and transformed cells. We first examined the human LAT exon/intron organization in the region neighboring the alternatively spliced intron 6 (Figure 1a) . By comparing LAT genomic sequences of human and several mammals, we designed sets of species-specific primers flanking intron 6 (Figure 1a; (Figure 1c) and it was comparable between normal cells and selected cancerous T-cell lines except for the MOLT-4 in which, because of chromosomal rearrangements, neither isoform of LAT was detected. Upon phorbol myristate acetate/phytohemagglutinin stimulation that mimicked a strong T-cell receptor (TCR) stimulation, the expression of both isoforms of LAT was upregulated ( Figure 1c) . Interestingly, when assessed on cytoplasmic RNA from peripheral blood leukocytes of the mouse, the cat, the dog, the pig and the cow, differences in relative proportions of LAT i6 versus LAT transcripts were scored. The LAT i6 transcript was virtually absent from the mouse but it was predominant in the cow. In the pig and the dog, the level of intron-retaining transcript roughly equaled that of the intronless LAT isoform, whereas in the cat the frequency of LAT i6 was lower than that of LAT transcript. From these analyses we conclude that the LAT i6 expression is evolutionary conserved in the humans and in at least four other mammals, but it is absent from the mouse. In the cow it constitutes a predominantly expressed splicing variant of LAT. The proportion between LAT/LAT i6 isoforms in the human T-cell lines is similar to that observed in nontransformed cells.
Point mutations in guanine trinucleotide sequences affect LAT i6 expression To gain insight into mechanisms responsible for variable frequency of LAT i6 expression in mammalian species, we examined cis-regulatory elements known to influence splicing efficiency. The strength of four core splicing signals (that is, 5 0 splice donor sequences (5 0 ss), 3 0 splice acceptor sequences (3 0 ss), BP and polypyrimidine tract) was scored using Sroogle online tool 36 on a collection of 18 LAT intron 6 sequences of eutherian mammals available in Ensembl Genome Database. The results of this analysis (Supplementary Table 2) showed that the intron 6 in all LAT i6 -expressing species is flanked by suboptimal (o9 bits) or low (o2 bits in the cow) strength 5 0 ss and variable strength 3 0 ss splicing signals, and contains medium strength BP and polypyrimidine tract elements. Surprisingly, in species predicted to exclude the LAT intron 6, the core splicing signal strengths also showed variability (Supplementary Table 2 ), questioning its predictive value as to the splicing outcome for a given species. This finding suggested that other cis-regulatory elements may play a role in exon/intron definition. Sequence alignment of LAT intron 6 shown in Figure 2a revealed variable number of conserved polyguanine trinucleotide elements known to act as enhancers of splicing. In the mouse, the density of ISE GGG was higher near the 5 0 ss and there was a unique G 4 NG 4 motif upstream of BP site. Such tandem elements were previously shown to greatly enhance splicing efficiency of human HLA-DQB1 intron 3. 13 Given that the number of ISE GGG inversely correlated with the experimentally observed frequencies of LAT i6 expression (Figures 1b and 2a) , we directly assessed the effect of loss-or gain-of-function point mutations introduced into these ISE GGG motifs. For this purpose we designed minigene splicing reporters encoding full-length human cDNA of LAT or LAT i6 variants, carrying mutations shown in Figure 2b . The loss-of-function mutation (hLATi6 M2G) inactivated two ISE GGG motifs and involved 2 G-C transversions and G-A transition. The gain-of-function mutation (hLATi6 P2G) produced two additional ISE GGG motifs following T-G, C-G and A-T transversions. In parallel, three control splicing reporters carrying an inactivating mutation of the consensus 5 0 ss signal (hLATi6); an intronless LAT cDNA (hLAT ); and a LAT i6 cDNA carrying no introduced mutations (hLATi6 wild type) were constructed. When transfected to the HEK 293T cell line, the hLATi6 wild type construct expressed both LAT i6 and LAT transcripts with roughly equal frequencies (Figure 2b ) whereas the loss-of-function hLATi6 M2G construct expressed on average 94% and 6% of LAT i6 and LAT transcripts, respectively. Inversely, the gain-of-function hLATi6 P2G construct promoted expression of LAT spliced variant (81%) over the LAT i6 (19%). Together, these data revealed that ISE GGG motifs are strongly involved in controlling expression of LAT i6 .
LAT i6 isoform undergoes expression, correct subcellular targeting and Fas-mediated degradation but displays a reduced half-life To assess whether LAT i6 produces a stable protein that is correctly targeted to the outer cell membrane, lentiviral constructs constitutively expressing Zs-Green fluorescent protein C-terminally fused to the human LAT i6 (hLAT i6 -Zs Green) or to the canonical human LAT (hLAT-Zs Green) were transduced into a LAT-deficient JCam2.5 cell line and subjected to live cell imaging. As shown in Figure 3a , the hLAT-Zs Green and the LAT i6 -Zs Green isoforms were expressed and similarly targeted to the outer plasma membrane and to the vesicular compartments. Inhibition of palmitoylation by 2-bromopalmitate treatment equally affected intracellular distribution of both LAT isoforms that predominantly accumulated as aggregates within Golgi apparatus. Stimulation of cells with plate-bound anti-CD3/CD28 monoclonal antibodies induced cell flattening and spreading. Both LAT isoforms displayed a similar pattern of distribution consisting of several discrete puncta localizing mainly at the cells edges that adhere to the plate surface. When anti-CD3/CD28 activatory beads were used for cell stimulation, LAT isoforms were equally enriched at the cell-bead interface. To biochemically analyze hLAT i6 intracellular localization, nuclei-depleted detergent-resistant membrane fractions of 6-histidine-tagged hLATi6 (hLAT i6 -his) or 6-histidinetagged hLAT (hLAT-his)-transduced JCam 2.5 cells and control Jurkat E6.1 and JCam 2.5 cells were immunoblotted with anti-LAT antibodies ( Figure 3b ). Both LAT isoforms were found predominantly in lipid raft-enriched fractions but were absent from cytoplasmic fractions. As the partial proteolytic degradation of LAT in response to pro-apoptotic stimuli was previously recognized as a mechanism for attenuation of T-cell signaling, 31, 32 we wished to examine whether JCam2.5 cells transduced with LAT i6 cDNA are prone to Fas-mediated degradation. In Figure 4a it is shown that upon anti-Fas crosslinking the LAT i6 was degraded similarly to the LAT isoform, indicating that an additional string of amino acids present in the LAT i6 does not change its sensitivity to Fas-induced degradation. We also considered that additional string of amino acids present in the LAT i6 may modify the protein stability. We therefore measured the hLAT i6 half-life by the cycloheximide chase assay. As shown in Figure 4b , the hLAT i6 isoform displayed a significantly reduced half-life in comparison with hLAT (t 1/ cells with proteasome inhibitor MG132 in the presence of CHX (Supplementary Figure 1) . This result suggested that proteasomeindependent mechanisms of protein degradation may be involved in controlling LAT protein turnover.
LAT i6 promotes TCR signaling and elevated IL-2 secretion upon prolonged CD3/CD28 crosslinking To investigate whether LAT i6 promotes TCR signal transduction, we performed signaling assays in JCam2.5 cells transduced with either LAT-or LAT i6 -expressing constructs. Upon TCR stimulation with anti-CD3 antibody, the kinetics and the extent of LAT C-terminal tyrosine phosphorylation (pY171, pY191) was found comparable for both LAT isoforms over a range of anti-CD3 antibody concentrations (Figure 5a and Supplementary Figure 2) . Next, phosphorylation levels of phospholipase C-g1 (PLC-g1) and extracellular signal-regulated kinase (ERK), which are downstream molecules coupling TCR signaling to calcium mobilization and CD69 elevation, were measured. Equal levels of PLC-g1 and ERK phosphorylation upon CD3 crosslinking and in consequence similar extent of calcium influx and CD69 (Figures 5b and c) elevation for both LAT isoforms were recorded (Figure 5a and Supplementary Figure 2) . These data indicated that the protein encoded by the LAT i6 isoform was fully functional in TCR signal transduction. IL-2 production by the JCam2.5 transductants stimulated with plate-bound anti-CD3/CD28 antibodies for 24 or 48 h was evaluated by enzyme-linked immunosorbent assay (ELISA; Figure 5d ). The amount of IL-2 detected in the cell culture supernatants did not show statistically significant differences between hLAT i6 -and hLAT-transduced cells after 24 h of stimulation, whereas it was reproducibly increased in the supernatants of LAT i6 -transduced cells after 48 h of stimulation (Figure 5d ).
DISCUSSION
In the present work we assessed whether an intron-retention event within the LAT gene, which we experimentally confirmed in five mammalian species, may lead to significant biological consequences. Often the biological relevance of intron retention is doubtful and hard to study because true IR events may be admixed with spurious products of splicing machinery. Three independent lines of evidence confirmed that LAT i6 undergoes expression. First, we detected LAT i6 transcripts in the cytoplasmic RNA of various normal and transformed human cells characterized by different transcriptional activity (Figure 1) . Second, the LAT i6 mRNA was present in the preparations of anucleate platelets, thus excluding contamination by genomic DNA and nuclear RNA. Third, in the cow the LAT i6 transcript was the only expressed splicing variant of LAT ( Figure 1 ). As the pre-mRNA splicing is regulated through combinatorial activity of core splice signals and splicing regulatory elements, we set out to examine the activity of these cis-acting elements. Previously, a G 4 NG 4 motif located upstream of BP site was shown to have a predominant activity in controlling human HLA-DQB1 intron 3 splicing. 13 Such an element is also present in the mouse (Figure 2a) , the rat and the hyrax (data not shown) LAT intron 6 but absent from species expressing LAT i6 . Point mutations within this element dramatically increased the LAT intron 6 retention (Figure 2b) , supporting its major role in controlling splicing efficiency. From an evolutionary perspective the observed interspecies variation in the LAT i6 expression may be typical of emerging new exons subjected to selection for maintenance or ignorance of the new biological function. 1, 37 Consistently, the observed predominant expression of the LAT i6 transcripts in the cow proves that a possible outcome of this selection process may be the intron 6 inclusion. This outcome is also in agreement with global alternative splicing analyses showing that short introns whose sequences do not change the open reading frame of transcripts tend to be positively selected for inclusion. 2 Immunofluorescence and western blotting analysis of human LAT i6 -transduced JCam2.5 cells directly confirmed that the LAT i6 isoform can be translated into protein. Yet, it is also possible that in species expressing both LAT isoforms the efficiency of LAT i6 translation may vary (A Miazek, unpublished observation), thus contributing to reduction of LAT gene expression at the level of transcript stability. 38 Considering that the human LAT i6 displayed a substantially reduced half-life (Figure 4b ), we speculate that this property may contribute to a more efficient signal attenuation during T-cell response. Indeed, slowing down the protein turnover of LAT was shown to enhance TCR signaling. 30 Conversely, evolutionary selection of the LAT i6 isoform may decrease the duration of TCR signaling, thus contributing to a better proofreading control of T-cell stimulation. 39 Our observation of increased IL-2 secretion upon prolonged CD3/CD28 crosslinking of LAT i6 -expressing JCam2.5 cells underpins a more efficient response to a persistent high-affinity TCR signaling. Reportedly, however, LAT expression is downregulated by an increase in intracellular calcium ion signaling. 40 We hypothesize that a possible way to maintain an optimal level of LAT expression upon sustained T-cell activation could be to intermittently halt signal transduction by dissipating LAT containing signaling clusters. As this would occur more frequently for the short-lived LAT i6 isoform, it could explain a higher efficiency of effector response as measured by an increase in IL-2 secretion. Further experimental studies, especially using bovine T lymphocytes, that represent a physiological model of LAT i6 expression will be needed to test the above hypothesis.
In summary, we identified LAT i6 as encoding a signalingcompetent, short-lived variant of LAT adaptor detectable in at least five mammalian species.
MATERIALS AND METHODS
Cell lines and isolation of peripheral blood mononuclear cells and platelets
Human acute lymphocytic leukemia cell lines, CCRF-CEM, HuT-78, JCaM 2.5, Jurkat clone E6.1 and MOLT-4, were maintained in RPMI-1640 medium and HEK 293T cell line was maintained in Dulbecco's modified Eagle's medium.
The basal media were supplemented with 10% fetal bovine serum (HyClone, Thermo Scientific, South Logan, UT, USA), 2 mM L-glutamine (Sigma-Aldrich, St Louis, MO, USA) and 1% streptomycin/penicillin (SigmaAldrich) and the cells were cultured in a 5% CO 2 humidified incubator at 37 1C. Human peripheral blood samples were obtained from healthy adult volunteers under an informed consent. The study was approved by the Local Bioethical Commission at the University of Cadiz (2013-05-21 Informe Aguado-Vidal). Leftovers of animal blood samples taken for periodic blood checks were obtained from the veterinary diagnostic laboratory at the Environmental and Life Sciences University of Wroclaw (Wroclaw, Poland). Murine blood samples were taken from the retro-orbital sinus of mice under permission (number 43/2013) of the first Local Ethical Commission in Wroclaw. Peripheral blood mononuclear cells were isolated by standard Ficoll-Hypaque gradient centrifugation (Lymphodex, Fresenius Diagnostics, Wiesbaden, Germany) followed by two washing steps in phosphatebuffered saline. To obtain leukocyte-free platelet fraction, the whole blood was repeatedly centrifuged at 128 and 200 g to remove nucleated cells. Supernatants enriched in platelets were collected by centrifugation at 3500 g and washed twice in phosphate-buffered saline before RNA isolation. The absence of nucleated cells was confirmed by flow cytometry. For Jurkat cell stimulation, cells were cultured overnight in the presence of phorbol myristate acetate (10 ng ml À 1 , Sigma-Aldrich) and phytohemagglutinin (5 mg ml À 1 , Sigma-Aldrich) and then LAT cDNA was quantified by quantitative PCR as described above.
Cell staining and sorting
For cell surface staining, fluorescent antibody and streptavidin conjugates to the following human antigens were used: anti-CD3 PerCP-efluor 710, anti-CD56PE, anti-CD69 biotin and streptavidin-APC, streptavidin-PECy7 (all from eBiosciences, San Diego, CA, USA). The cells were stained for 30 min on ice, washed twice in phosphate-buffered saline þ 2% fetal bovine serum and analyzed in a Calibur Flow Cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). T-cell (CD3 þ CD56 À ) and NK cell (CD3 À CD56 þ ) subset purification was performed by flow cytometry using BD Aria II cell sorter (Beckton Dickinson). The purity of sorted cells, assessed by flow cytometry, exceeded 97%.
Cytoplasmic RNA isolation, cDNA synthesis and conventional PCR Cytoplasmic RNA was purified using RNeasy Mini kit (Qiagen, Valencia, CA, USA) and treated with DNase I (Qiagen) according to the manufacturer's protocol. RNA was reverse-transcribed using SuperScript III First-Strand Synthesis kit (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) and used in conventional PCRs with DreamTaq DNA Polymerase (Fermentas, Thermo Fisher Scientific). Species-specific primer pairs flanking LAT intron 6 are shown in Supplementary Table 1.
Quantitative RT-PCR
The qRT-PCR assay was performed in two technical replicates per sample on an ABI 7300 (Applied Biosystems, Foster City, CA, USA) apparatus. Amplifications were carried out with 5xHOT FIREPol EvaGreen qPCR Mix Plus with ROX (Solis BioDyne, Tartu, Estonia). Each qRT-PCR run included 5 ng of human T and NK cell cDNA and the reaction conditions were as follows: 15 min at 95 1C followed by 40 cycles of 15 s at 95 1C, 30 s at 61 1C and 30 s at 72 1C. To control for the formation of primer dimers and unspecific amplification products, the melting curve analysis was employed. The relative expression was normalized to EF1a1 and HPRT1 for nuclear cells or to GAPDH gene for the platelets. 41 The nucleotide sequences of primers used for the qRT-PCR are listed in Supplementary Table 1. Splicing reporter construction and transfection to HEK 293T cells Point mutations in the LAT full-length cDNA containing intron 6 were introduced using PCR site-directed mutagenesis with specific sets of primers listed in Supplementary Table 1 collected and cytoplasmic RNA was isolated as described above. PCR was performed using F3/R4 primers (see Supplementary Table 1) . PCR products were resolved on agarose gels and quantified using ImageJ Software (NIH, Bethesda, MD, USA).
Lentiviral particle production and transfection of JCam2.5 cells
The cDNA encoding human LAT i6 or LAT isoforms in fusions with C-terminally 6-histidine tags or Zs-Green fluorescent protein cDNA were cloned into the self-inactivating (SIN) lentiviral transfer plasmid pHR'SINcPPT-Blast as previously described. 31 Lentiviral particles containing supernatants were used to transduce JCam2.5 cells. Stably transduced cells were selected using 10 mg ml À 1 of blasticidin. The expression level of LAT isoforms was assessed by western immunoblotting.
Microscopy
Live cell imaging was performed on Zeiss LSM510 confocal microscope (Zeiss, Oberkochen, Germany) equipped with a temperature-and CO 2 -controlled stage (PECON GmbH, Erbach, Germany) and Â 40 water immersion C-Apochromat (NA 1.2) objective. Cells were transferred into 8-chamber slide Lab-Tek II (Nunc, Waltham, MA, USA) with cover-glass bottom covered with poly-L-lysine. To stimulate cells we used the chambers with bottom coated with mouse monoclonal anti-human CD3 (10 mg ml À 1 ) and anti-human CD28 antibodies (1 mg ml À 1 ) (eBiosciences). Chambers with cells were immediately placed onto the microscope stage (37 1C/5% CO 2 ) and left for 5 min for gas and temperature equilibration. Then, spreading cells were identified in transmitted light mode and imaged. Cells with no apparent or little motion were chosen for imaging. Single optical sections (1 mm) with pinhole set to 1 Airy unit were acquired with 0.14 mm per pixel lateral resolution. Fluorescence was excited with 488 nm argon laser line and for signal detection we used LP505 emission filter (Zeiss). Laser power and detector settings were adjusted in order to avoid autofluorescence detection. In addition, to stimulate cells in a different way, we employed beads covered with mouse monoclonal anti-human CD3 and anti-human CD28 antibodies (Life Technologies, Thermo Fisher Scientific). Beads were added directly to chamber with cells placed on the microscope stage. Then, cells attaching to the bead were found and imaging was started. To inhibit palmitoylation, cells were incubated with 2-bromopalmitate (60 mM) for 16 h. Then, cells were imaged as described above.
Western immunoblotting and cycloheximide chase
Cell suspensions of lymphoid organs or peripheral blood mononuclear cells were lysed in RIPA buffer (50 mM HEPES (pH 7.4), 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40 and 20 mM methyl-bcyclodextrin) that was freshly supplemented with protease inhibitor mixtures (Sigma-Aldrich) and 10 mM Na 3 VO 4 . Next, 10 mg of total protein was resolved by 12% SDS-polyacrylamide gel electrophoresis and electroblotted onto PVDF membranes (Millipore, Billerica, MA, USA). Chemiluminescence detection of LAT (clone 06-807, Millipore) and b-actin (clone AC-15, Sigma-Aldrich) was carried as described previously. was performed as previously described. 28 Cells were treated with 0.1 mM cycloheximide for up to 12 h. Every 2 h, cell samples were lysed in RIPA buffer. LAT protein levels were determined by immunoblotting and quantified by densitometry with ImageJ software (NIH).
Cell fractionation
Detergent-resistant membrane fractions enriched in lipid rafts were prepared by the successive detergent extraction method exactly as described elsewhere. 42 After fractionation, proteins were resolved by SDSpolyacrylamide gel electrophoresis and immunoblotted with anti-LAT (Millipore GmbH, Vienna, Austria) and anti ZAP-70 antibodies (Santa Cruz Biotechnology, Dallas, TX, USA) according to the manufacturer's protocols.
Measurement of intracellular Ca2 þ mobilization
Cells were stained with Indo-1 AM dye (2 mM) (Molecular Probes, Invitrogen, Thermo Fisher Scientific) as previously described. 28 Calcium measurements were performed using a Synergy MX Multi-Mode Reader (Biotek, Winooski, VT, USA) at 37 1C. The cells were excited with light of 340 nm wavelength and the light emitted at 405 nm and 485 were collected alternatively once a second. Calcium mobilization was evaluated by ratio of the 405/485 nm fluorescence signal. 
Bioinformatics
Splicing Regulation Online Graphical Engine (Sroogle) 36 tool available at http://sroogle.tau.ac.il/ was used for scoring core splicing elements of LAT intron 6 from various mammalian species. Multiple sequence alignments were performed with the ClustalW2 43 online tool at http://www.ebi.ac.uk. 
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